Editorials |
From the Division of Cardiovascular Medicine (K.A.G., N.C.), University of California, Davis, Davis, Calif; Department of Veterans Affairs (N.C.), Northern California Health Care System, Mather, Calif.
Correspondence to Nipavan Chiamvimonvat, Division of Cardiovascular Medicine, University of California, Davis, One Shields Ave, TB 172, Davis, CA 95616. E-mail nchiamvimonvat{at}ucdavis.edu
Key Words: long-QT syndrome Na+ currents SCN5A sinus node dysfunction
Congenital long-QT syndrome (LQTS) is a group of inherited disorders that is associated with a prolonged QT interval on the ECG. It can be associated with syncope and sudden death due to episodic cardiac arrhythmias, particularly torsades de pointes and ventricular fibrillation. One common familial form is inherited as an autosomal dominant trait (the Romano-Ward syndrome). Much progress toward understanding the molecular mechanisms in congenital LQTS has been made over the past 8 years. Mutations in several ion channel genes have been discovered in different families with LQTS: KVLQT1, HERG, SCN5A, minK, MiRP115 (for review see6). Indeed, these studies provided the first molecular basis into the pathogenesis of cardiac arrhythmias and, importantly, possible new insights into the more common types of acquired LQTS such as cardiomyopathy, ischemia, as well as drug-induced LQTS.7
SCN5A, located on chromosome 3p21-24, encodes the
subunit of cardiac Na+ channels.8 Mutation analyses have revealed
30 distinct mutations of SCN5A associated with LQTS type 3 (LQT3).9 Mutations of KVLQT1, a gene that encodes for a slowly activating delayed rectifier K+ channel (IKs), cause LQT1, the most common form of LQTS.1 Mutations in the minK gene cause LQT5.4 Mutations in HERG have been linked to LQT23 and represent 45% of the known LQTS defects. This gene encodes
subunits that form cardiac IKr, a rapidly activating delayed-rectifier K+ channel. MiRP1, or minK-related protein 1, putatively coassembles with HERG
subunits to form cardiac IKr channels and has been associated with LQT6.5 More recently, a mutation in ankyrin-B (also known as ankyrin 2), a member of a family of membrane adapters, has been shown to underlie LQT4.10 Mutations in SCN5A associated with LQTS often destabilize the channel inactivation gate, leading to a resultant action potential (AP) prolongation, ie, gain-of-function mutations (LQT3). SCN5A mutations also cause familial ventricular fibrillation (Brugada syndrome) and are associated with loss-of-function mutations.6
Specific phenotypes have been associated with the three main genetic subtypes of LQT1 (IKs defect), LQT2 (IKr defect or the HERG mutation), and LQT3 (the Na+ channel mutation).11,12 LQT1 appears to be the most adrenaline-sensitive of the subtypes in that episodes frequently occur during exercise, swimming, or with strong emotion, and beta-blocker medications work well at reducing episodes in this subtype.13 LQT2 is classically associated with auditory stimuli, and these patients respond variably to beta-blockers.13,14 LQT3 is relatively rare, representing only 5% to 10% of all LQTS patients.6 They classically have episodes while sleeping, are believed to have the lowest event rate but highest mortality with events, and may respond well to pacemaker therapy alone.12,13,15 Bradycardia and sinus pauses have been documented in patients with LQT3,13 which may further predispose patients to lethal tachyarrhythmic events.
In this issue of Circulation Research, Veldkamp et al16 provide for the first time the possible molecular mechanism for the previously described bradyarrhythmias and occurrence of tachyarrhythmias in association with slow heart rate in LQT3 families. The investigators performed a detailed analysis of the contribution of Na+ channel mutations to sinoatrial (SA) node dysfunction using computer simulations and the previously published models of a rabbit SA nodal cell,17 as well as a second model described by Zhang et al for the peripheral SA nodal cell.18 A previously described 1795insD, a C-terminal SCN5A mutation that causes affected individuals to manifest electrocardiographic features of QT-interval prolongation (LQT3) at slow heart rates and distinctive ST-segment elevations (Brugada syndrome) with exercise, was used for the analysis. The mutant 1795insD Na+ channel results in an incomplete inactivation and persistent Na+ current (INa) as well as a negative shift in voltage dependence of inactivation.19,20 It was quite convincingly predicted from the two different SA nodal cell models that persistent INa per se slows sinus rate by increasing the SA nodal cell AP duration even though the rate of diastolic depolarization (DDR) was increased, and that a negative shift in inactivation per se slows sinus rate by decreasing the availability of the inward current during phase 4 diastolic depolarization with a resultant decrease in DDR. Indeed, at a critical value of persistent INa, oscillations occurred at the plateau potentials and the model cells failed to repolarize. Importantly, the sinus slowing effects of the two determinants are almost additive. The Figure shows a schematic Venn diagram of the various SCN5A mutations, the resultant phenotypes, and some possible overlaps.
|
The interpretation of the model cell data are dependent on the premise that some Na+ channels remain available at the moderately depolarized membrane potential in pacemaking cells. In the last three decades, a large body of evidence has accumulated with regard to the ionic mechanisms underlying mammalian cardiac pacemaker activity. Spontaneous activity in SA node cells results from a characteristic phase of their APs, the slow diastolic depolarization.21 During this phase, the membrane slowly depolarizes until the threshold for a new AP is reached. The slow diastolic depolarization results from a number of ionic currents, including the hyperpolarization-activated inward current, If, an inward T-type Ca2+ current, ICa,T, inward L-type Ca2+ currents, ICa,L, and the acetylcholine-induced K+ current, IK,ACh.2125 In addition, a number of studies have reported an important functional role of INa in adult SA nodal cells.22,26 Veldkamp et al16 further tested for this possibility using AP clamp experiments to test the contribution of the INa during SA nodal automaticity. For 1795insD mutant channels, the upstroke of the AP generated a small and fast inward peak INa, and a small persistent INa could be appreciated throughout the repolarization phase, explaining the increase in the AP duration as predicted from the models.
Future studies will be needed to further address whether other types of LQT mutations can be associated with SA node dysfunction and how this may further contribute to QT prolongation and the ensuing tachyarrhythmias. For example, IKr has also been shown to contribute to repolarization and pacemaking in the SA node of mammalian heart. Class III antiarrhythmic methanesulfonanilide drugs such as dofetilide, at concentrations that block IKr selectively, reduce the spontaneous pacing rate and slow the rate of repolarization of single mammalian SA nodal cells.27 It will be important to assess whether LQT2 families also show evidence of SA node dysfunction and more importantly the therapeutic implication in the treatment in these patients.
Acknowledgments
This work was supported by the Department of Veterans Affairs Merit Review Grant and NIH Grants HL68507 and HL67737 (to N.C.) and the Pfizer/SWHR Scholar Grant (to K.A.G.). The authors thank Dr Ebenezer N. Yamoah for helpful discussions.
Footnotes
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
References
1. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996; 12: 1723.[CrossRef][Medline] [Order article via Infotrieve]
2. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995; 80: 805811.[CrossRef][Medline] [Order article via Infotrieve]
3. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995; 80: 795803.[CrossRef][Medline] [Order article via Infotrieve]
4. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997; 17: 338340.[Medline] [Order article via Infotrieve]
5. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999; 97: 175187.[CrossRef][Medline] [Order article via Infotrieve]
6. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001; 104: 569580.[CrossRef][Medline] [Order article via Infotrieve]
7. Roden DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. 1998; 21: 10291034.[CrossRef][Medline] [Order article via Infotrieve]
8. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics. 1996; 34: 916.[CrossRef][Medline] [Order article via Infotrieve]
9. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000; 102: 11781185.
10. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003; 421: 634639.[CrossRef][Medline] [Order article via Infotrieve]
11. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992; 327: 846852.[Abstract]
12. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998; 339: 960965.
13. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001; 103: 8995.
14. Wilde AA, Jongbloed RJ, Doevendans PA, Duren DR, Hauer RN, van Langen IM, van Tintelen JP, Smeets HJ, Meyer H, Geelen JL. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol. 1999; 33: 327332.
15. van den Berg MP, Wilde AA, Viersma TJW, Brouwer J, Haaksma J, van der Hout AH, Stolte-Dijkstra I, Bezzina TCR, Van Langen IM, Beaufort-Krol GC, Cornel JH2nd, Crijns HJ. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol. 2001; 12: 630636.[CrossRef][Medline] [Order article via Infotrieve]
16. Veldkamp MW, Wilders R, Baartscheer A, Zegers JG, Bezzina CR, Wilde AAM. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res. 2003; 92: 976983.
17. Wilders R, Jongsma HJ, van Ginneken AC. Pacemaker activity of the rabbit sinoatrial node: a comparison of mathematical models. Biophys J. 1991; 60: 12021216.[Medline] [Order article via Infotrieve]
18. Zhang H, Holden AV, Kodama I, Honjo H, Lei M, Varghese T, Boyett MR. Mathematical models of action potentials in the periphery and center of the rabbit sinoatrial node. Am J Physiol Heart Circ Physiol. 2000; 279: H397H421.
19. Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR. Two distinct congenital arrhythmias evoked by a multidysfunctional Na+ channel. Circ Res. 2000; 86: e91e97.[Medline] [Order article via Infotrieve]
20. Baroudi G, Chahine M. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. FEBS Lett. 2000; 487: 224228.[CrossRef][Medline] [Order article via Infotrieve]
21. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 1993; 55: 455472.[CrossRef][Medline] [Order article via Infotrieve]
22. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000; 47: 658687.
23. Zhang H, Holden AV, Noble D, Boyett MR. Analysis of the chronotropic effect of acetylcholine on sinoatrial node cells. J Cardiovasc Electrophysiol. 2002; 13: 465474.[CrossRef][Medline] [Order article via Infotrieve]
24. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat N. Functional roles of Cav1.3 (
1D) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res. 2002; 90: 981987.
25. Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell. 2000; 102: 8997.[CrossRef][Medline] [Order article via Infotrieve]
26. Baruscotti M, DiFrancesco D, Robinson RB. A TTX-sensitive inward sodium current contributes to spontaneous activity in newborn rabbit sino-atrial node cells. J Physiol. 1996; 492: 2130.
27. Verheijck EE, van Ginneken AC, Bourier J, Bouman LN. Effects of delayed rectifier current blockade by E-4031 on impulse generation in single sinoatrial nodal myocytes of the rabbit. Circ Res. 1995; 76: 607615.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |